Epysqli Ευρωπαϊκή Ένωση - Τσεχικά - EMA (European Medicines Agency)

epysqli

samsung bioepis nl b.v. - ekulizumab - hemoglobinurie, paroxysmální - imunosupresiva - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Bekemv Ευρωπαϊκή Ένωση - Τσεχικά - EMA (European Medicines Agency)

bekemv

amgen technology (ireland) uc - ekulizumab - hemoglobinurie, paroxysmální - imunosupresiva - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). důkazy o klinické prospěšnosti je prokázána u pacientů s hemolýza s klinickým příznakem(s) svědčí o vysoké aktivity nemoci, bez ohledu na to, transfúze historie (viz bod 5.